Thymosin Alpha-1 Capsule (500mcg)
$60.00
Thymosin Alpha-1 Capsule (500mcg), boasting an exceptional 99% purity, is designed exclusively for research purposes. As one of the most sought-after synthetic peptides, it offers unparalleled precision for academic, clinical, and experimental studies. Each capsule is meticulously formulated to support reliable and consistent results, catering to researchers who demand quality and consistency in their work.
Unmatched Purity for Reliable Research Outcomes
Thymosin Alpha-1 Capsule (500mcg), boasting an exceptional 99% purity, is designed exclusively for research purposes. As one of the most sought-after synthetic peptides, it offers unparalleled precision for academic, clinical, and experimental studies. Each capsule is meticulously formulated to support reliable and consistent results, catering to researchers who demand quality and consistency in their work.
Why Choose Thymosin Alpha-1 for Your Research?
Known for its immunomodulatory properties, Thymosin Alpha-1 has been widely studied for its role in immune system regulation, making it a prime candidate for investigating therapeutic potential in various conditions. This capsule, presented in a precise 500mcg dose, ensures optimal usability while maintaining a stringent focus on accuracy. Its cutting-edge synthesis process guarantees the highest purity and integrity, aligning perfectly with your advanced research needs.
Strictly for Research Use
Please note that Thymosin Alpha-1 Capsule is strictly intended for research purposes only and is not suitable for human or veterinary consumption. Researchers are encouraged to handle the product responsibly, adhering to proper protocols and safety measures. Whether you’re conducting biochemical experiments or investigating possible medical applications, this product is an indispensable addition to your research resources.
| Weight | 1 lbs |
|---|---|
| Dimensions | 4 × 2 × 2 in |
Only logged in customers who have purchased this product may leave a review.

Reviews
There are no reviews yet.